A recent study proposed an AID/APOBEC-derived survival model for ovarian cancer risk assessment and revealed that the network is particularly associated with remodeling/fibrotic pathways, altered immune response, and autoimmune disorders with inflammatory background [14]. This evidence concerns the gene AICDA and ovarian carcinoma.